BIOCON
|
The Current P/S Ratio of BIOCON is 4.09.
| Share Price | ₹425.2 | Aug 04,2026 |
| Market Cap | ₹69,286.7 Cr | |
| Sales-TTM | ₹16,927.0 Cr | TTM-Consolidated Results |
| Price/Sales | 4.09x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BIOCON
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹69,286.7 Cr] as on Aug 04,2026
(/) Sales [ ₹16,927.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.09x ]
Thus, for BIOCON , the investors are currently willing to pay '4.09 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BIOCON !
The chart below summarizes the trend in P/S Ratio of BIOCON over the last five years.
Historical PS (Price/Sales) ratio chart of BIOCON
PS Ratio Performance Analysis for BIOCON
- BIOCON 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 3.08x.
- BIOCON 's operated at median p/e ratio of 2.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/e ratio peaked in Mar2022 at 4.91x.
- BIOCON 's p/e ratio hit its five-year low in Mar2024 of 2.15x.
How does BIOCON 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BIOCON | 16,927.0 | 4.09 | 69,286.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.85 | 470,270.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 19.79 | 222,224.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.17 | 191,325.0 |
| CIPLA LTD | 28,324.4 | 4.14 | 117,139.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.92 | 96,876.6 |
| MANKIND PHARMA LTD | 14,737.9 | 6.90 | 101,638.0 |
| LUPIN LTD | 27,958.0 | 3.89 | 108,639.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.11 | 111,571.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.71 | 91,128.4 |
| LAURUS LABS LTD | 7,269.6 | 13.64 | 99,174.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BIOCON 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.71x |
| Max industry PS | 19.79x |
| Median industry PS | 4.14x |
| Average industry PS | 7.47x |
You may also like the below Video Courses